vs
Assertio Holdings, Inc.（ASRT）与Pathfinder Bancorp, Inc.（PBHC）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是Pathfinder Bancorp, Inc.的1.1倍（$13.5M vs $11.8M），Pathfinder Bancorp, Inc.同比增速更快（-22.6% vs -57.9%），过去两年Pathfinder Bancorp, Inc.的营收复合增速更高（3.0% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Pathfinder Bancorp, Inc.是美国区域性银行控股公司，旗下运营探路者银行，服务纽约州中部市场，为个人消费者及中小企业提供存款账户、住房抵押贷款、商业贷款、财富管理等各类金融服务。
ASRT vs PBHC — 直观对比
营收规模更大
ASRT
是对方的1.1倍
$11.8M
营收增速更快
PBHC
高出35.3%
-57.9%
两年增速更快
PBHC
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $11.8M |
| 净利润 | — | $-5.6M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | -81.1% |
| 净利率 | — | -52.9% |
| 营收同比 | -57.9% | -22.6% |
| 净利润同比 | — | -242.4% |
| 每股收益（稀释后） | $-4.54 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTPBHC
| Q4 25 | $13.5M | $11.8M | ||
| Q3 25 | $49.5M | $13.1M | ||
| Q2 25 | $29.2M | $9.3M | ||
| Q1 25 | $26.5M | $12.6M | ||
| Q4 24 | $32.2M | $15.3M | ||
| Q3 24 | $29.2M | $13.4M | ||
| Q2 24 | $31.1M | $10.7M | ||
| Q1 24 | $32.4M | $11.1M |
净利润ASRTPBHC
| Q4 25 | — | $-5.6M | ||
| Q3 25 | $11.4M | $626.0K | ||
| Q2 25 | $-16.4M | $31.0K | ||
| Q1 25 | $-13.5M | $3.0M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | $-2.9M | $-4.6M | ||
| Q2 24 | $-3.7M | $2.0M | ||
| Q1 24 | $-4.5M | $2.1M |
营业利润率ASRTPBHC
| Q4 25 | -86.7% | -81.1% | ||
| Q3 25 | 23.2% | 5.1% | ||
| Q2 25 | -27.5% | 0.4% | ||
| Q1 25 | -50.0% | 29.5% | ||
| Q4 24 | -41.9% | 55.4% | ||
| Q3 24 | -10.4% | -43.1% | ||
| Q2 24 | -11.6% | 23.3% | ||
| Q1 24 | -13.4% | 24.3% |
净利率ASRTPBHC
| Q4 25 | — | -52.9% | ||
| Q3 25 | 23.1% | 4.8% | ||
| Q2 25 | -56.0% | 0.3% | ||
| Q1 25 | -51.1% | 23.6% | ||
| Q4 24 | — | 37.7% | ||
| Q3 24 | -10.0% | -34.6% | ||
| Q2 24 | -11.8% | 18.7% | ||
| Q1 24 | -13.9% | 19.0% |
每股收益（稀释后）ASRTPBHC
| Q4 25 | $-4.54 | — | ||
| Q3 25 | $0.11 | $0.47 | ||
| Q2 25 | $-0.17 | $0.47 | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-3.28 | — | ||
| Q3 24 | $-0.03 | $0.41 | ||
| Q2 24 | $-0.04 | $0.41 | ||
| Q1 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | $14.1M |
| 股东权益账面价值 | $94.0M | $122.5M |
| 总资产 | $267.0M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资ASRTPBHC
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTPBHC
| Q4 25 | — | $14.1M | ||
| Q3 25 | — | $18.7M | ||
| Q2 25 | — | $21.0M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | — | $27.1M | ||
| Q3 24 | — | $39.8M | ||
| Q2 24 | — | $45.9M | ||
| Q1 24 | $38.6M | $45.9M |
股东权益ASRTPBHC
| Q4 25 | $94.0M | $122.5M | ||
| Q3 25 | $105.8M | $126.3M | ||
| Q2 25 | $93.3M | $124.4M | ||
| Q1 25 | $108.5M | $124.9M | ||
| Q4 24 | $121.1M | $121.5M | ||
| Q3 24 | $130.5M | $120.2M | ||
| Q2 24 | $132.2M | $123.3M | ||
| Q1 24 | $134.5M | $121.8M |
总资产ASRTPBHC
| Q4 25 | $267.0M | $1.4B | ||
| Q3 25 | $319.8M | $1.5B | ||
| Q2 25 | $273.8M | $1.5B | ||
| Q1 25 | $286.4M | $1.5B | ||
| Q4 24 | $284.7M | $1.5B | ||
| Q3 24 | $276.0M | $1.5B | ||
| Q2 24 | $279.4M | $1.4B | ||
| Q1 24 | $282.0M | $1.5B |
负债/权益比ASRTPBHC
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | 0.29× | 0.38× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $11.7M |
| 自由现金流经营现金流 - 资本支出 | — | $10.4M |
| 自由现金流率自由现金流/营收 | — | 88.1% |
| 资本支出强度资本支出/营收 | — | 10.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $18.4M |
8季度趋势，按日历期对齐
经营现金流ASRTPBHC
| Q4 25 | $-30.0M | $11.7M | ||
| Q3 25 | $-4.8M | $7.0M | ||
| Q2 25 | $19.1M | $-3.7M | ||
| Q1 25 | $-12.5M | $5.7M | ||
| Q4 24 | $11.5M | $11.2M | ||
| Q3 24 | $-35.0K | $11.8M | ||
| Q2 24 | $7.4M | $1.5M | ||
| Q1 24 | $7.5M | $504.0K |
自由现金流ASRTPBHC
| Q4 25 | — | $10.4M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | — | $-4.0M | ||
| Q1 25 | — | $5.1M | ||
| Q4 24 | — | $9.1M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $637.0K | ||
| Q1 24 | — | $274.0K |
自由现金流率ASRTPBHC
| Q4 25 | — | 88.1% | ||
| Q3 25 | — | 52.8% | ||
| Q2 25 | — | -42.6% | ||
| Q1 25 | — | 40.1% | ||
| Q4 24 | — | 59.9% | ||
| Q3 24 | — | 84.3% | ||
| Q2 24 | — | 6.0% | ||
| Q1 24 | — | 2.5% |
资本支出强度ASRTPBHC
| Q4 25 | — | 10.7% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 13.5% | ||
| Q3 24 | 0.0% | 3.8% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 2.1% |
现金转化率ASRTPBHC
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | 11.26× | ||
| Q2 25 | — | -120.55× | ||
| Q1 25 | — | 1.92× | ||
| Q4 24 | — | 2.87× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
PBHC
| Other | $5.6M | 47% |
| Banking | $3.7M | 31% |
| Deposit Account | $1.5M | 13% |
| Financial Service Other | $1.0M | 9% |
